These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1789925)

  • 1. A comparison between the effect of intentional modulations and the action of L-dopa on gait in Parkinson's disease.
    Ferrandez AM; Blin O
    Behav Brain Res; 1991 Nov; 45(2):177-83. PubMed ID: 1789925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease.
    Blin O; Ferrandez AM; Pailhous J; Serratrice G
    J Neurol Sci; 1991 May; 103(1):51-4. PubMed ID: 1865232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.
    Faist M; Xie J; Kurz D; Berger W; Maurer C; Pollak P; Lücking CH
    Brain; 2001 Aug; 124(Pt 8):1590-600. PubMed ID: 11459750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease.
    Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
    Mov Disord; 2015 Sep; 30(10):1361-70. PubMed ID: 26095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease .
    MacKay-Lyons M
    Phys Ther; 1998 Oct; 78(10):1083-94. PubMed ID: 9781702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease.
    Defebvre LJ; Krystkowiak P; Blatt JL; Duhamel A; Bourriez JL; Périna M; Blond S; Guieu JD; Destée A
    Mov Disord; 2002 Jan; 17(1):76-83. PubMed ID: 11835442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Automatic motion analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations].
    Azulay JP; Van Den Brand C; Mestre D; Blin O; Sangla I; Pouget J; Serratrice G
    Rev Neurol (Paris); 1996 Feb; 152(2):128-34. PubMed ID: 8761620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease.
    Ferrarin M; Rizzone M; Lopiano L; Recalcati M; Pedotti A
    Gait Posture; 2004 Apr; 19(2):164-71. PubMed ID: 15013505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
    Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
    Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the electromyographic patterns of lower limb muscles during gait in patients with Parkinson's disease when OFF and ON L-Dopa treatment.
    Cioni M; Richards CL; Malouin F; Bedard PJ; Lemieux R
    Ital J Neurol Sci; 1997 Aug; 18(4):195-208. PubMed ID: 9323513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait.
    Stolze H; Klebe S; Poepping M; Lorenz D; Herzog J; Hamel W; Schrader B; Raethjen J; Wenzelburger R; Mehdorn HM; Deuschl G; Krack P
    Neurology; 2001 Jul; 57(1):144-6. PubMed ID: 11445647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
    Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
    J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new method of quantitative analysis of parkinsonian gait: report of 6 patients].
    Blin O; Ferrandez AM; Pailhous J; Serratrice G
    Rev Neurol (Paris); 1990; 146(1):48-50. PubMed ID: 2309059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
    Cantiniaux S; Vaugoyeau M; Robert D; Horrelou-Pitek C; Mancini J; Witjas T; Azulay JP
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):177-84. PubMed ID: 19793764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Morris M; Iansek R; Matyas T; Summers J
    Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies of segmental stabilization during gait in Parkinson's disease.
    Mesure S; Azulay JP; Pouget J; Amblard B
    Exp Brain Res; 1999 Dec; 129(4):573-81. PubMed ID: 10638431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.